Arbor Biotechnologies Funding & Investors
Cambridge, MA
Arbor Biotechnologies operator of a bio-discovery company intended to provide human diagnostic development service. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.
arbor.bioTotal Amount Raised: $304,500,000
Arbor Biotechnologies Funding Rounds
Series C
$73,900,000
Series C Investors
Arch Venture PartnersTCG Crossover ManagementRevelation PartnersPartners InvestmentQatar Investment AuthorityAlly Bridge GroupArrowMark Colorado HoldingsDeep Track CapitalTemasek HoldingsT. Rowe PriceSurveyor CapitalVertex PharmaceuticalsPiper Heartland Healthcare CapitalStandard Life AberdeenKerna VenturesSeries B
$215,000,000
Series B Investors
Ally Bridge GroupTCG Crossover ManagementTemasek HoldingsS32Woodline PartnersRidgeback Capital ManagementGreatPoint VenturesT. Rowe PriceHenderson Global InvestorsIllumina VenturesOno Venture InvestmentVertex PharmaceuticalsDeep Track CapitalSurveyor CapitalTekla Capital ManagementArch Venture PartnersTao Capital PartnersLogos CapitalArrowMark Colorado HoldingsSeries A
$15,600,000
Series A Investors
Arch Venture PartnersAlexandria Real Estate Equities
Funding info provided by Diffbot.